Conference Paper: Telbivudine Globe Trial: Maximal Early HBV Suppression is Predictive of Optimal Two-year Efficacy in Nucleoside-treated Hepatitis B Patients
File Download
(May Require Subscription)
- No File Attached
(May Require Subscription)
- Find via
Supplementary
-
Citations:
-
Appears in Collections:
| Title | Telbivudine Globe Trial: Maximal Early HBV Suppression is Predictive of Optimal Two-year Efficacy in Nucleoside-treated Hepatitis B Patients |
|---|---|
| Authors | DiBisceglie A, A Lai, CL Gane, E Chen, YC Thongsawat, S Wang, YM Chen, YG Heathcote, EJ Zeuzem, S Rasenack, J Bzowej, N Han, SH Naoumov, N Hwang, SG Lim, SG Chao, GC Fielman, BA Brown, NA Study Group The GLOBE, |
| Issue Date | 2006 |
| Publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/ |
| Citation | Hepatology, v. 44 n. Suppl 1, p. 231A [How to Cite?] |
| ISSN | 0270-9139 2011 Impact Factor: 11.665 2011 SCImago Journal Rankings: 1.278 |
| dc.contributor.author | DiBisceglie A, A |
|---|---|
| dc.contributor.author | Lai, CL |
| dc.contributor.author | Gane, E |
| dc.contributor.author | Chen, YC |
| dc.contributor.author | Thongsawat, S |
| dc.contributor.author | Wang, YM |
| dc.contributor.author | Chen, YG |
| dc.contributor.author | Heathcote, EJ |
| dc.contributor.author | Zeuzem, S |
| dc.contributor.author | Rasenack, J |
| dc.contributor.author | Bzowej, N |
| dc.contributor.author | Han, SH |
| dc.contributor.author | Naoumov, N |
| dc.contributor.author | Hwang, SG |
| dc.contributor.author | Lim, SG |
| dc.contributor.author | Chao, GC |
| dc.contributor.author | Fielman, BA |
| dc.contributor.author | Brown, NA |
| dc.contributor.author | Study Group The GLOBE, |
| dc.date.accessioned | 2010-09-25T20:12:49Z |
| dc.date.available | 2010-09-25T20:12:49Z |
| dc.date.issued | 2006 |
| dc.identifier.citation | Hepatology, v. 44 n. Suppl 1, p. 231A [How to Cite?] |
| dc.identifier.hkuros | 133900 |
| dc.identifier.issn | 0270-9139 2011 Impact Factor: 11.665 2011 SCImago Journal Rankings: 1.278 |
| dc.identifier.issue | Suppl 1 |
| dc.identifier.openurl | |
| dc.identifier.spage | 231 |
| dc.identifier.uri | http://hdl.handle.net/10722/101994 |
| dc.identifier.volume | , v. 44 n. Suppl 1 |
| dc.language | eng |
| dc.publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/ |
| dc.relation.ispartof | Hepatology |
| dc.rights | Hepatology. Copyright © John Wiley & Sons, Inc. |
| dc.title | Telbivudine Globe Trial: Maximal Early HBV Suppression is Predictive of Optimal Two-year Efficacy in Nucleoside-treated Hepatitis B Patients |
| dc.type | Conference_Paper |